Page 40 - Morphosys This News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys this. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys This Today - Breaking & Trending Today

MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma

MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma
MUNICH, GERMANY and CAMBRIDGE, MA / ACCESSWIRE / June 2, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ( MorphoSys ), announces today that it has entered into a definitive agreement with Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) ( Constellation ) whereby MorphoSys will acquire Constellation for $34.00 per share in cash, which represents a total equity value of $1.7 billion. The transaction has been unanimously approved by the Management Board (
Vorstand) and the Supervisory Board (
Aufsichtsrat) of MorphoSys, as well as the Board of Directors of Constellation and is expected to close in the third quarter of 2021. ....

United States , United Kingdom , Julia Neugebauer , Novarti Promacta , Myles Clouston , Merck Januvia , Development Funding Bonds , Janssen Biotech Inc , Morphosys Development Inc , Drug Administration , Constellation Pharmaceuticals Inc , Janssen Research Development , Morphosys Us Inc , Frankfurt Stock Exchange , Exchange Commission , Million Development Funding Bonds , Constellation Pharmaceuticals , Management Board , Supervisory Board , Royalty Pharma , Upfront Payment , Frankfurt Stock , Hart Scott Rodino Antitrust Improvements Act , Janssen Research , Janssen Biotech , Tender Offer Statement ,

MorphoSys To Buy Constellation Pharma In $1.7 Bln Deal; In Funding Partnership With Royalty Pharma

MARTINSRIED (dpa-AFX) - German biotechnology company MorphoSys AG (MOR, MPSYY.PK) on Wednesday announced that it has entered into a definitive agreement to acquire Constellation Pharmaceuticals ....

Development Funding Bonds , Constellation Pharmaceuticals Inc , Frankfurt Stock Exchange , Constellation Pharmaceuticals , Royalty Pharma , Constellation Pharma , Frankfurt Stock , விண்மீன் மருந்துகள் இன்க் , பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் , விண்மீன் மருந்துகள் , ராயல்டி பார்மா , பிராங்க்ஃபர்ட் ஸ்டாக் ,

German biotech company MorphoSys buys US rival for $1.7B

BERLIN (AP) Germany-based MorphoSys AG said Wednesday that it is buying U.S. rival. ....

United Kingdom , Constellation Pharmaceuticals Inc , Germany Based Morphosys , Constellation Pharmaceuticals , Royalty Pharma , Western Europe , Bob Berlin , B Germany , Constellation Pharmaceuticals Inc , C Complete State National , Urope News , A Wire , Usiness Stories , Ews Health Stories , Op News , Usiness News , F Wire , Hoice Plus , Royalty Pharma , ஒன்றுபட்டது கிஂக்டம் , விண்மீன் மருந்துகள் இன்க் , விண்மீன் மருந்துகள் , ராயல்டி பார்மா , ெசிதேர்ந் யூரோப் , ஓப் செய்தி , எஃப் கம்பி ,

MorphoSys to buy Constellation Pharma in a $1.7B bet on epigenetic cancer drugs

MedCity News
MorphoSys to buy Constellation Pharma in a $1.7B bet on epigenetic cancer drugs
MorphoSys is acquiring Constellation Pharmaceuticals and its late-stage myelofibrosis drug in a deal that values the epigenetics biotech at $1.7 billion. Germany-based MorphoSys will finance the acquisition with cash from a separate $2 billion deal with drug royalty acquirer Royalty Pharma.
Shares0

MorphoSys, a biotech that has spent much of its three-decade history developing drugs that ended up at other companies via partnerships or licensing deals, is now building up its own pipeline through a $1.7 billion acquisition of Constellation Pharmaceuticals.
Constellation will bring to MorphoSys clinical-stage drugs and expertise in epigenetics, the study of turning genes on or off without altering the genetic code. That research has yielded a Phase 3 drug candidate for a rare blood cancer, as well as another compound in mid-stage testing with the potential to brin ....

United States , United Kingdom , Constellation Pharmaceuticals , Germany Based Morphosys , Massachusetts Based Constellation , Cambridge Based Elizma , Malte Peters , Morphosys Chief Financial Officer Sung Lee , Royalty Pharma , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery ,

Royalty Pharma Reaches $2.025 Bln Strategic Funding Partnership With MorphoSys

MARTINSRIED (dpa-AFX) - Royalty Pharma plc (RPRX) said that it has reached a $2.025 billion strategic funding partnership with MorphoSys AG (MOR), as part of MorphoSys' $1.7 billion acquisition ....

Janssen Tremfya , Constellation Pharmaceuticals , Royalty Pharma , விண்மீன் மருந்துகள் , ராயல்டி பார்மா ,